News & Media

Latest Press Release

November 13, 2018

BioSig Technologies Announces New Research Program with Mayo Clinic

New Agreement to Focus on Enhanced Features of PURE EP System and Future Potential Clinical Applications Santa Monica, CA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company entered into a new advanced research agreement with Mayo Clinic in Rochester,…

Read More